↓ Skip to main content

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

Overview of attention for article published in Frontiers in oncology, October 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
Published in
Frontiers in oncology, October 2023
DOI 10.3389/fonc.2023.1276138
Pubmed ID
Authors

Andrea Alberti, Gertraud Stocker, Florian Lordick, Ulrich T. Hacker, Benjamin Kobitzsch, Ivonne Haffner, Gian Luca Baiocchi, Manuel Zamparini, Guido A. M. Tiberio, Carla Baronchelli, Arnaldo Caruso, Paolo Bossi, Alfredo Berruti

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 1 100%
Readers by discipline Count As %
Medicine and Dentistry 1 100%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 November 2023.
All research outputs
#15,124,227
of 26,180,352 outputs
Outputs from Frontiers in oncology
#4,018
of 22,924 outputs
Outputs of similar age
#145,729
of 370,460 outputs
Outputs of similar age from Frontiers in oncology
#93
of 912 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,924 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,460 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 912 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.